157 related articles for article (PubMed ID: 30141910)
1. Molecular Basis for Allosteric Inhibition of GTP-Bound H-Ras Protein by a Small-Molecule Compound Carrying a Naphthalene Ring.
Matsumoto S; Hiraga T; Hayashi Y; Yoshikawa Y; Tsuda C; Araki M; Neya M; Shima F; Kataoka T
Biochemistry; 2018 Sep; 57(36):5350-5358. PubMed ID: 30141910
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for conformational dynamics of GTP-bound Ras protein.
Shima F; Ijiri Y; Muraoka S; Liao J; Ye M; Araki M; Matsumoto K; Yamamoto N; Sugimoto T; Yoshikawa Y; Kumasaka T; Yamamoto M; Tamura A; Kataoka T
J Biol Chem; 2010 Jul; 285(29):22696-705. PubMed ID: 20479006
[TBL] [Abstract][Full Text] [Related]
3. The small GTPases K-Ras, N-Ras, and H-Ras have distinct biochemical properties determined by allosteric effects.
Johnson CW; Reid D; Parker JA; Salter S; Knihtila R; Kuzmic P; Mattos C
J Biol Chem; 2017 Aug; 292(31):12981-12993. PubMed ID: 28630043
[TBL] [Abstract][Full Text] [Related]
4. Shift in the equilibrium between on and off states of the allosteric switch in Ras-GppNHp affected by small molecules and bulk solvent composition.
Holzapfel G; Buhrman G; Mattos C
Biochemistry; 2012 Aug; 51(31):6114-26. PubMed ID: 22845804
[TBL] [Abstract][Full Text] [Related]
5. Discovery of small-molecule Ras inhibitors that display antitumor activity by interfering with Ras·GTP-effector interaction.
Shima F; Yoshikawa Y; Matsumoto S; Kataoka T
Enzymes; 2013; 34 Pt. B():1-23. PubMed ID: 25034098
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of the state 1 conformer of GTP-bound H-Ras protein and distinct dynamic properties between the state 1 and state 2 conformers.
Araki M; Shima F; Yoshikawa Y; Muraoka S; Ijiri Y; Nagahara Y; Shirono T; Kataoka T; Tamura A
J Biol Chem; 2011 Nov; 286(45):39644-53. PubMed ID: 21930707
[TBL] [Abstract][Full Text] [Related]
7. K-Ras
Feng H; Zhang Y; Bos PH; Chambers JM; Dupont MM; Stockwell BR
Biochemistry; 2019 May; 58(21):2542-2554. PubMed ID: 31042025
[TBL] [Abstract][Full Text] [Related]
8. Conformational states of Ras complexed with the GTP analogue GppNHp or GppCH2p: implications for the interaction with effector proteins.
Spoerner M; Nuehs A; Ganser P; Herrmann C; Wittinghofer A; Kalbitzer HR
Biochemistry; 2005 Feb; 44(6):2225-36. PubMed ID: 15697248
[TBL] [Abstract][Full Text] [Related]
9. Structural insight into the rearrangement of the switch I region in GTP-bound G12A K-Ras.
Xu S; Long BN; Boris GH; Chen A; Ni S; Kennedy MA
Acta Crystallogr D Struct Biol; 2017 Dec; 73(Pt 12):970-984. PubMed ID: 29199977
[TBL] [Abstract][Full Text] [Related]
10. Small molecule binding sites on the Ras:SOS complex can be exploited for inhibition of Ras activation.
Winter JJ; Anderson M; Blades K; Brassington C; Breeze AL; Chresta C; Embrey K; Fairley G; Faulder P; Finlay MR; Kettle JG; Nowak T; Overman R; Patel SJ; Perkins P; Spadola L; Tart J; Tucker JA; Wrigley G
J Med Chem; 2015 Mar; 58(5):2265-74. PubMed ID: 25695162
[TBL] [Abstract][Full Text] [Related]
11. Conformational transitions in p21ras and in its complexes with the effector protein Raf-RBD and the GTPase activating protein GAP.
Geyer M; Schweins T; Herrmann C; Prisner T; Wittinghofer A; Kalbitzer HR
Biochemistry; 1996 Aug; 35(32):10308-20. PubMed ID: 8756686
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the structural flexibility of the complex p21(ras)-GTP: the catalytic conformation of the molecular switch II.
Soares TA; Miller JH; Straatsma TP
Proteins; 2001 Dec; 45(4):297-312. PubMed ID: 11746677
[TBL] [Abstract][Full Text] [Related]
13. Bifunctional Small-Molecule Ligands of K-Ras Induce Its Association with Immunophilin Proteins.
Zhang Z; Shokat KM
Angew Chem Int Ed Engl; 2019 Nov; 58(45):16314-16319. PubMed ID: 31557383
[TBL] [Abstract][Full Text] [Related]
14. Mammalian Ras interacts directly with the serine/threonine kinase Raf.
Vojtek AB; Hollenberg SM; Cooper JA
Cell; 1993 Jul; 74(1):205-14. PubMed ID: 8334704
[TBL] [Abstract][Full Text] [Related]
15. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.
Ostrem JM; Peters U; Sos ML; Wells JA; Shokat KM
Nature; 2013 Nov; 503(7477):548-51. PubMed ID: 24256730
[TBL] [Abstract][Full Text] [Related]
16. In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction.
Shima F; Yoshikawa Y; Ye M; Araki M; Matsumoto S; Liao J; Hu L; Sugimoto T; Ijiri Y; Takeda A; Nishiyama Y; Sato C; Muraoka S; Tamura A; Osoda T; Tsuda K; Miyakawa T; Fukunishi H; Shimada J; Kumasaka T; Yamamoto M; Kataoka T
Proc Natl Acad Sci U S A; 2013 May; 110(20):8182-7. PubMed ID: 23630290
[TBL] [Abstract][Full Text] [Related]
17. Identification of the sites of interaction between c-Raf-1 and Ras-GTP.
Barnard D; Diaz B; Hettich L; Chuang E; Zhang XF; Avruch J; Marshall M
Oncogene; 1995 Apr; 10(7):1283-90. PubMed ID: 7731678
[TBL] [Abstract][Full Text] [Related]
18. Peptides containing a consensus Ras binding sequence from Raf-1 and theGTPase activating protein NF1 inhibit Ras function.
Clark GJ; Drugan JK; Terrell RS; Bradham C; Der CJ; Bell RM; Campbell S
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1577-81. PubMed ID: 8643674
[TBL] [Abstract][Full Text] [Related]
19. K-Ras Populates Conformational States Differently from Its Isoform H-Ras and Oncogenic Mutant K-RasG12D.
Parker JA; Volmar AY; Pavlopoulos S; Mattos C
Structure; 2018 Jun; 26(6):810-820.e4. PubMed ID: 29706533
[TBL] [Abstract][Full Text] [Related]
20. Design of Small Molecules That Compete with Nucleotide Binding to an Engineered Oncogenic KRAS Allele.
Zhang Y; Larraufie MH; Musavi L; Akkiraju H; Brown LM; Stockwell BR
Biochemistry; 2018 Feb; 57(8):1380-1389. PubMed ID: 29313669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
